Impact of histology and toxicities on outcomes of patients with muscle invasive bladder cancer receiving neoadjuvant chemotherapy.

Authors

null

Catherine Curran

Dana Farber Cancer Institute, Boston, MA

Catherine Curran , Gregory Russell Pond , Andres Acosta , Amin Nassar , Sarah Abou Alaiwi , Matthew D. Ingham , Mark A. Preston , Graeme S. Steele , Kerry L. Kilbridge , Bradley Alexander McGregor , Matthew Mossanen , Guru Sonpavde

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers

Track

Urothelial Carcinoma,Adrenal Cancer,Penile Cancer,Prostate Cancer - Advanced,Prostate Cancer - Localized,Testicular Cancer,Urethral Cancer

Sub Track

Translational Research

Citation

J Clin Oncol 38, 2020 (suppl 6; abstr 540)

Abstract #

540

Poster Bd #

K21

Abstract Disclosures